Quetiapine in recently relapsed patients with schizophrenia: An open-label head-to-head comparative study versus olanzapine

被引：0
作者：
Reznik, I
Lilia, S
Shabash, E
Shaked, G
Kertzman, S
Spivak, B
Kotler, M
Weizman, A
机构：
[1] Beer Yaakov Mental Hlth Ctr, Ness Ziona, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Psychiat, IL-69978 Tel Aviv, Israel
来源：
EUROPEAN PSYCHIATRY | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：178S / 178S
页数：1
相关论文
共 50 条
  • [21] An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia
    Mozes, Tamar
    Ebert, Tanya
    Michal, Sabbagh-Etun
    Spivak, Baruch
    Weizman, Abraham
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (04) : 393 - 403
  • [22] Olanzapine in Chinese treatment-resistant patients with schizophrenia: An open-label, prospective trial
    Chiu, NY
    Yang, YK
    Chen, PS
    Chang, CC
    Lee, IH
    Lee, JR
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2003, 57 (05) : 478 - 484
  • [23] Aripiprazole versus olanzapine in a 52-week, open-label extension study
    McQuade, R
    Kostic, D
    Marcus, R
    Carson, W
    Torbeyns, A
    Kerselaers, W
    Yocca, F
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 496 - 497
  • [24] Olanzapine Added to Roluperidone, in Patients With Schizophrenia and Negative Symptoms, a Safety Open-Label Trial
    Davidson, Michael
    Luthringer, Remy
    Saoud, Jay
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 160 - 160
  • [25] Comparative assessment of effect on psychomotor performance efficacy and adherence of levosulpiride and olanzapine in patients with schizophrenia: A parallel, open-label, prospective observational study
    Pramoda, N.
    Turankar, V. Avinash
    Thakre, Manish Namdeo
    Mahajan, Sudhir Laludeo
    Mahakalkar, Sunil
    Shetty, Ashwita Uday
    Sasi, Sandeep M.
    ANNALS OF INDIAN PSYCHIATRY, 2023, 7 (04) : 339 - 344
  • [26] A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia
    Perez, Victor
    Canas, Fernando
    Tafalla, Monica
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (03) : 138 - 149
  • [27] Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study
    Lamberti, Marco
    Siracusano, Rosamaria
    Italiano, Domenico
    Alosi, Norma
    Cucinotta, Francesca
    Di Rosa, Gabriella
    Germano, Eva
    Spina, Edoardo
    Gagliano, Antonella
    PEDIATRIC DRUGS, 2016, 18 (04) : 319 - 329
  • [28] QUETIAPINE AUGMENTATION OF AMISULPRIDE: AN OPEN-LABEL, NON-RANDOMIZED STUDY IN PATIENTS WITH SCHIZOPHRENIA PARTIALLY RESPONSIVE TO AMISULPRIDE
    Ladea, M.
    Dumitrescu, M. R.
    Sarpe, M. C.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [29] Not all head-to-head trials are created equal: Results from an open-label, short-term study seem inconsistent with previous donepezil literature
    Bullock, R
    Truyen, L
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (01) : 85 - 87
  • [30] Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
    Gabriel, Adel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 711 - 717
12345